Trade Summary

3 days ago, Hall Brett Matthew, serving as CHIEF SCIENTIFIC OFFICER at Immuneering Corp (IMRX), purchased 6,035 shares at $4.15 per share, for a total transaction value of $25,045.25. Following this transaction, Hall Brett Matthew now holds 382,531 shares of IMRX.

This purchase represents a 1.60% increase in Hall Brett Matthew's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 4:15 PM ET, 1 day after the trade was made.

Immuneering Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.